《大行報告》花旗下調瑞聲(02018.HK)目標價至38元 評級「中性」
花旗發表報告指,瑞聲科技(02018.HK)第三季業績表現遜預期,多個分部季度毛利率持續下跌,相信主因越南疫情導致產能利用率較預期低,加上晶片出現短缺及產品均價下降。
展望未來,該行預期蘋果公司(AAPL.US)鏡頭模組的供應問題可逐步解決,而組件需求問題亦將逐步走出困境。不過,該行認爲集團仍需時改善毛利表現。
花旗維持瑞聲股份「中性」評級,目標價由45元降至38元,並調低集團今年至2023年各年盈利預測分別25%、29%及23%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.